You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

CLINICAL TRIALS PROFILE FOR ELOBIXIBAT

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for Elobixibat

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT01007123 ↗	Study of Elobixibat (A3309) in Patients With Chronic Idiopathic Constipation	Completed	Albireo	Phase 2	The purpose of this trial is to determine the efficacy and safety of A3309 administered to patients with chronic idiopathic constipation.
NCT01038687 ↗	Effect of Ileal Bile Acid Transporter Inhibitor in Functional Constipation	Completed	National Center for Research Resources (NCRR)	Phase 2	This is a single-center, randomized, parallel group, double-blind, placebo-controlled, dose response, pharmacodynamic and pharmacokinetic study evaluating the effects of A3309 on gastric, intestinal and colonic transit in patients with functional constipation.
NCT01038687 ↗	Effect of Ileal Bile Acid Transporter Inhibitor in Functional Constipation	Completed	Mayo Clinic	Phase 2	This is a single-center, randomized, parallel group, double-blind, placebo-controlled, dose response, pharmacodynamic and pharmacokinetic study evaluating the effects of A3309 on gastric, intestinal and colonic transit in patients with functional constipation.
NCT01038687 ↗	Effect of Ileal Bile Acid Transporter Inhibitor in Functional Constipation	Completed	Michael Camilleri, MD	Phase 2	This is a single-center, randomized, parallel group, double-blind, placebo-controlled, dose response, pharmacodynamic and pharmacokinetic study evaluating the effects of A3309 on gastric, intestinal and colonic transit in patients with functional constipation.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for Elobixibat

Condition Name

Chart
Table

Condition Name
Intervention	Trials
Chronic Constipation	4
Chronic Idiopathic Constipation	4
Constipation	2
Nonalcoholic Steatohepatitis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH
Intervention	Trials
Constipation	10
Non-alcoholic Fatty Liver Disease	2
Fatty Liver	1
Liver Diseases	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Elobixibat

Trials by Country

Map
Table

Trials by Country
Location	Trials
United States	103
South Africa	12
Poland	10
Canada	9
Germany	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State
Location	Trials
Florida	5
California	5
Texas	5
Arizona	4
Virginia	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Elobixibat

Clinical Trial Phase

Chart
Table

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	4
Phase 2	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status
Clinical Trial Phase	Trials
Completed	4
Not yet recruiting	2
Recruiting	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Elobixibat

Sponsor Name

Chart
Table

Sponsor Name
Sponsor	Trials
Ferring Pharmaceuticals	4
Yokohama City University	3
Albireo	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type
Sponsor	Trials
Industry	8
Other	6
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.